When a patent dispute over the rich rights to a human growth hormone ended four weeks ago in San Francisco federal court, the University of California staggered out bruised but largely victorious.

Jurors tossed out opponent Genentech Inc.’s claim that UC’s 1982 patent wasn’t enabled, or adequate for use by other scientists. And they deadlocked 8-1 in favor of UC’s claim that Genentech had infringed on the school’s patent.